secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2022-05-18T23:59:59+00:00
Accession:  0001193125-22-154024
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CSO Bruce Car resigns from Agios, effective July 31, 2022
---------------------------------------------------------

- Bruce Car, Ph.D., Chief Scientific Officer, notified his resignation on May 15, 2022.
- Resignation effective July 31, 2022; no replacement named as of filing date.
- Voluntary departure; no reason or disagreement disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522154024/0001193125-22-154024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522154024/d345515d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-154024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer